HOOK - HOOKIPA Pharma Inc.
1.88
0 0%
Share volume: 346
Last Updated: Wed 05 Feb 2025 12:00:04 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.33%
PREVIOUS CLOSE
CHG
CHG%
$1.88
0.00
0.00%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-03-22 | 2024-05-09 | 2024-05-09 | 2024-08-08 | 2024-11-14 | |
| Assets | |||||||||
| Total Assets | 163.088 M | 191.110 M | 164.010 M | 161.337 M | 145.871 M | 145.871 M | 125.046 M | 109.730 M | |
| Current Assets | 139.913 M | 168.143 M | 139.471 M | 147.116 M | 132.710 M | 132.710 M | 107.351 M | 93.156 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 11.850 M | 12.095 M | 8.745 M | 10.749 M | 20.557 M | 9.190 M | 22.479 M | 24.666 M | |
| Short Term Investments | 11.850 M | 12.095 M | 8.745 M | 10.749 M | 0.000 | 9.190 M | 0.000 | 0.000 | |
| Total Receivables | 18.463 M | 20.461 M | 23.050 M | 19.271 M | 0.000 | 30.769 M | 0.000 | 0.000 | |
| Current Cash | 109.600 M | 135.587 M | 107.676 M | 117.096 M | 92.751 M | 92.751 M | 77.150 M | 59.750 M | |
| Total Non-current Assets | 23.175 M | 22.967 M | 24.539 M | 14.221 M | 0.000 | 13.161 M | 0.000 | 0.000 | |
| Property Plant Equipment | 17.975 M | 18.222 M | 20.167 M | 7.742 M | 7.332 M | 7.332 M | 7.007 M | 6.860 M | |
| Other Assets | 4.779 M | 4.323 M | 3.953 M | 6.054 M | 5.829 M | 5.625 M | 10.688 M | 9.714 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 163.088 M | 191.110 M | 164.010 M | 161.337 M | 145.871 M | 145.871 M | 125.046 M | 109.730 M | |
| Total liabilities | 79.609 M | 78.780 M | 68.959 M | 71.480 M | 41.349 M | 41.349 M | 38.982 M | 37.928 M | |
| Total current liabilities | 44.209 M | 46.245 M | 40.576 M | 41.988 M | 29.508 M | 29.508 M | 27.834 M | 28.568 M | |
| Accounts Payable | 7.075 M | 11.645 M | 8.929 M | 12.498 M | 11.201 M | 11.201 M | 11.314 M | 8.955 M | |
| Other liabilities | 33.428 M | 30.883 M | 27.053 M | 25.691 M | 9.224 M | 8.487 M | 9.217 M | 7.681 M | |
| Current long term debt | 3.786 M | 2.628 M | 2.524 M | 2.758 M | 0.000 | 2.728 M | 0.000 | 0.000 | |
| Long term debt | 1.972 M | 1.652 M | 1.330 M | 3.801 M | 0.000 | 3.354 M | 0.000 | 0.000 | |
| Other liabilities | 33.428 M | 30.883 M | 27.053 M | 25.691 M | 9.224 M | 8.487 M | 9.217 M | 7.681 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 83.479 M | 112.330 M | 95.051 M | 89.857 M | 104.522 M | 104.522 M | 86.064 M | 71.802 M | |
| Common stock | 72.218 M | 82.705 M | 110.388 M | 112.795 M | 466.802 M | 125.388 M | 467.261 M | 468.200 M | |
| Retained earnings | -307.361 M | -325.377 M | -344.443 M | -369.261 M | -354.878 M | -354.878 M | -373.973 M | -387.814 M |